FL Senate Approves Bill Requiring Form for Asbestos Lawsuits
The Florida Senate voted to approve Republican Senator Travis Hutson’s proposed SB 720 requiring courts to dismiss asbestos claims without a completed information form. The bill’s next stop is the Florida House of Representatives.
If the House approves the measure, it would then go before the governor. If signed into law, those with asbestos-related diseases will have to provide more extensive information when filing a lawsuit.
SB 720 has the backing of businesses. Lobbying groups including the U.S. Chamber of Commerce and the Florida Insurance Council also support the measure.
However, veterans groups a...
Source: Asbestos and Mesothelioma News - March 11, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos (general) Asbestos Exposure Asbestosis Cancer (Non-Meso) Florida Legal Lawsuit Mesothelioma Source Type: news
Nonprofit Teams With Firefighter Union for Asbestos Ban Campaign
The Asbestos Disease Awareness Organization is teaming with the International Association of Fire Fighters on a new anti-asbestos campaign. In a continued push toward a national ban of the toxic mineral, the organizations have created a 120 foot high and 84 foot wide billboard in New York City’s Times Square.
A firefighter in full gear is the focal point of the advertisement. Written on the picture are the words: “Firefighters Face Risk.” Under that in large red letters it reads: “Ban Asbestos Now.”
The message is expected to make 1.5 million impressions a day and will be seen 4 times every hour for 1...
Source: Asbestos and Mesothelioma News - February 6, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos (general) Asbestos Exposure Awareness/Advocacy Mesothelioma Support/Support Groups/Organizations Source Type: news
J & J to Pay $700 Million to Settle Talc Baby Powder Investigation
Johnson & Johnson’s $700 million deal will resolve a talcum powder investigation a group of 43 State Attorneys Generals launched. J&J is accused of not warning people about potential health risks linked to its talc-based baby powder.
This latest settlement won’t resolve thousands of other lawsuits that claim the company’s talc-based products cause cancer. In total 50,000 claims have been filed against J&J, the majority of which claim the company’s talc caused ovarian cancer. J&J maintains that its products don’t cause cancer.
“I view this settlement as part of J&J’s overall str...
Source: Asbestos and Mesothelioma News - January 24, 2024 Category: Environmental Health Authors: Daniel Mojica Tags: Asbestos (general) Asbestos Exposure johnson Litigation Mesothelioma Settlement Source Type: news
Firefighters Union Advocates for Total U.S. Asbestos Ban
A representative of the International Association of Fire Fighters appeared before a congressional subcommittee recently to push for a total ban of asbestos in the United States. The IAFF represents thousands of firefighters in the U.S. and Canada.
The labor union is supporting the Alan Reinstein Ban Asbestos Now Act of 2023, which would amend the federal Toxic Substances Control Act. The bill is named for Reinstein, who died in 2006 from mesothelioma after he was exposed to asbestos.
If passed, the legislation would prohibit the use and importation of all six types of asbestos. More than 70 countries have alr...
Source: Asbestos and Mesothelioma News - September 12, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos (general) Asbestos Exposure Awareness/Advocacy Source Type: news
Libby Clinic Files for Bankruptcy After Asbestos Claims Ruling
The Center for Asbestos Related Disease in Libby, Montana, has filed for Chapter 11 bankruptcy protection. The decision comes after a jury ruled in June that CARD had submitted 337 false asbestos claims, forcing the clinic to pay nearly $6 million in penalties and damages.
BNSF Railway filed the lawsuit against CARD under the federal False Claims Act. The act allows private parties to file a lawsuit on the federal government’s behalf. The suit accuses the clinic of failing to get outside confirmation that hundreds of patients had an asbestos-related illness.
The railroad company, owned by billionaire Warren B...
Source: Asbestos and Mesothelioma News - August 28, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Legal Treatment Source Type: news
What Are Treatments for Recurrent Respiratory Papillomatosis?
Discussion
Human papilloma virus (HPV) is a member of the Papillomaviridae virus family with over a 150 different subtypes. HPV can cause cervical, genital and respiratory tract papillomas. HPV is often benign but can cause anogenital, cervical and head and neck cancers.
Recurrent respiratory papillomatosis (RRP) is uncommon but can cause significant morbidity while awaiting the body’s immune system to respond. There is a juvenile and adult form, and the incidence varies between 2-4/100,000 in the pediatric population. The juvenile form frequently occurs between 3.6-6 years of age and in general the younger the patie...
Source: PediatricEducation.org - July 31, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
UK Parliament, Riddled With Asbestos, Faces Restoration Delays
Lawmakers say that Britain’s Palace of Westminster is at risk of demolition because the iconic and historic structure needs several costly repairs, including asbestos removal.
Nearly 120 workers and other people inside the palace were potentially exposed to asbestos during a 2022 renovation in the speaker’s residential space. In addition to asbestos and its cancer risks, the building is rife with leaks and is crumbling in areas.
Some are worried the entire structure, in which both houses of Parliament meet, is at risk in the event of a catastrophic incident. A report from the House of Commons Public Accounts Comm...
Source: Asbestos and Mesothelioma News - May 25, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Mesothelioma Source Type: news
Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
This study evaluates an investigational combination regimen of IMBRUVICA® (ibrutinib) plus venetoclax (I+V) for newly diagnosed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), (Abstracts #7535 and #P617, respectively).Advancing the Science of Solid Tumors Through Precision MedicineJanssen’s continued innovation in solid tumors focuses on advancing precision medicine options for patients with biomarker-driven disease who have limited targeted treatment options and moving patients into earlier lines of therapy when treatments may be more effective. Lung CancerAn oral presentation will report ...
Source: Johnson and Johnson - May 18, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news
AHA News: Missouri Man Turns Heart Disease Diagnosis Into Public Service Message
WEDNESDAY, March 29, 2023 (American Heart Association News) -- Don Young already had been through an excruciating ordeal with throat cancer that included removal of his larynx, multiple hospitalizations and a doctor ' s prediction of six months to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 29, 2023 Category: General Medicine Source Type: news
Larysuicide: an online risk stratification system to identify patients at high risk of suicide after the laryngeal cancer diagnosis - Tu Z, Li C, Hu Q, Luo J.
In this study, we aimed to develop an online risk stratification system, named Larysuicide, to identify patients at high ri... (Source: SafetyLit)
Source: SafetyLit - February 14, 2023 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX ® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
NEW ORLEANS, December 12, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (D-Rd), evaluating progression-free survival (PFS), minimal residual disease (MRD) negativity and overall response rate (ORR) at a median follow-up of 64.5 months, and overall survival (OS) at a median follow-up of 73.6 months in newly diagnosed, transplant-ineligible (TIE) patients with multiple myeloma, regardless of patients’ age and across clinically important subgroups, as well as health...
Source: Johnson and Johnson - December 12, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Asbestos Health Screenings in Libby, Montana, Expanding
Highly specialized asbestos exposure health screenings in Libby, Montana, have gone mobile.
In an effort to identify lung abnormalities at their earliest stage, the groundbreaking Center for Asbestos Related Disease – known as CARD – has begun touring the state, offering its services to those unable or unwilling to travel.
The efforts have been well received.
Libby is a small town in rural northwest Montana that is home to one of the largest human-made environmental disasters and longest-running asbestos cleanup project in American history.
Although restoration is all but complete in the scenic and charming...
Source: Asbestos and Mesothelioma News - September 20, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Mesothelioma Source Type: news
Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX ® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma
LOS ANGELES, August 27, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the final results from the randomized Phase 2 GRIFFIN study evaluating the investigational use of DARZALEX® (daratumumab) in combination with lenalidomide (Revlimid®), bortezomib (VELCADE®) and dexamethasone (DARZALEX®-RVd), followed by maintenance therapy with DARZALEX®-lenalidomide (R), compared to RVd followed by maintenance therapy with R alone, in patients with newly diagnosed, transplant-eligible multiple myeloma. Data were presented in the plenary session at the 19th International Myeloma Society (IMS)...
Source: Johnson and Johnson - August 28, 2022 Category: Pharmaceuticals Source Type: news
Expert Alert: Options for laryngeal regeneration
PHOENIX, Ariz. — Mayo Clinic is using 3D printing as a new option to heal the larynx after cancer or traumatic injury. David Lott, M.D., a Mayo Clinic otolaryngologist and head and neck surgeon, is an expert who can speak about a pioneering procedure using 3D bioimplants and tissue engineering to regenerate the larynx, more commonly known as the voice box. Dr. Lott also is the associate director of the Center for Regenerative Medicine at… (Source: Mayo Clinic Arizona News)
Source: Mayo Clinic Arizona News - August 2, 2022 Category: Hospital Management Source Type: news
